The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Biological Multiplex Assays-Global Market Insights and Sales Trends 2024
Synopsis
Multiplex assays enables the simultaneous detection of multiple analytes in a single run/cycle of the assay.
The global Biological Multiplex Assays market size is expected to reach US$ 86 million by 2029, growing at a CAGR of 3.7% from 2023 to 2029. The market is mainly driven by the significant applications of Biological Multiplex Assays in various end use industries. The expanding demands from the Research And Development and Clinical Diagnosis, are propelling Biological Multiplex Assays market. Protein Assays, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Nucleic Acid Assays segment is estimated at % CAGR for the next seven-year period.
By geography, North America is expected to account for the largest share of the multiplex assays market in 2018, followed by Europe.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Biological Multiplex Assays, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Biological Multiplex Assays market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Biological Multiplex Assays market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Biological Multiplex Assays sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Biological Multiplex Assays covered in this report include Luminex, Thermo Fisher Scientific, Illumina, Bio-Rad Laboratories, Qiagen, Abcam, Becton Dickinson, Merck and Agilent Technologies, etc.
The global Biological Multiplex Assays market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Luminex
Thermo Fisher Scientific
Illumina
Bio-Rad Laboratories
Qiagen
Abcam
Becton Dickinson
Merck
Agilent Technologies
Meso Scale Diagnostics
Randox Laboratories
Quanterix
Bio-Techne
Olink
Global Biological Multiplex Assays market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Biological Multiplex Assays market, Segment by Type:
Protein Assays
Nucleic Acid Assays
Global Biological Multiplex Assays market, by Application
Research And Development
Clinical Diagnosis
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Biological Multiplex Assays companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Multiplex assays enables the simultaneous detection of multiple analytes in a single run/cycle of the assay.
The global Biological Multiplex Assays market size is expected to reach US$ 86 million by 2029, growing at a CAGR of 3.7% from 2023 to 2029. The market is mainly driven by the significant applications of Biological Multiplex Assays in various end use industries. The expanding demands from the Research And Development and Clinical Diagnosis, are propelling Biological Multiplex Assays market. Protein Assays, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Nucleic Acid Assays segment is estimated at % CAGR for the next seven-year period.
By geography, North America is expected to account for the largest share of the multiplex assays market in 2018, followed by Europe.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Biological Multiplex Assays, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Biological Multiplex Assays market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Biological Multiplex Assays market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Biological Multiplex Assays sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Biological Multiplex Assays covered in this report include Luminex, Thermo Fisher Scientific, Illumina, Bio-Rad Laboratories, Qiagen, Abcam, Becton Dickinson, Merck and Agilent Technologies, etc.
The global Biological Multiplex Assays market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Luminex
Thermo Fisher Scientific
Illumina
Bio-Rad Laboratories
Qiagen
Abcam
Becton Dickinson
Merck
Agilent Technologies
Meso Scale Diagnostics
Randox Laboratories
Quanterix
Bio-Techne
Olink
Global Biological Multiplex Assays market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Biological Multiplex Assays market, Segment by Type:
Protein Assays
Nucleic Acid Assays
Global Biological Multiplex Assays market, by Application
Research And Development
Clinical Diagnosis
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Biological Multiplex Assays companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Biological Multiplex Assays
1.1 Biological Multiplex Assays Market Overview
1.1.1 Biological Multiplex Assays Product Scope
1.1.2 Biological Multiplex Assays Market Status and Outlook
1.2 Global Biological Multiplex Assays Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Biological Multiplex Assays Market Size by Region (2018-2029)
1.4 Global Biological Multiplex Assays Historic Market Size by Region (2018-2023)
1.5 Global Biological Multiplex Assays Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Biological Multiplex Assays Market Size (2018-2029)
1.6.1 North America Biological Multiplex Assays Market Size (2018-2029)
1.6.2 Europe Biological Multiplex Assays Market Size (2018-2029)
1.6.3 Asia-Pacific Biological Multiplex Assays Market Size (2018-2029)
1.6.4 Latin America Biological Multiplex Assays Market Size (2018-2029)
1.6.5 Middle East & Africa Biological Multiplex Assays Market Size (2018-2029)
2 Biological Multiplex Assays Market by Type
2.1 Introduction
2.1.1 Protein Assays
2.1.2 Nucleic Acid Assays
2.2 Global Biological Multiplex Assays Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Biological Multiplex Assays Historic Market Size by Type (2018-2023)
2.2.2 Global Biological Multiplex Assays Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Biological Multiplex Assays Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Biological Multiplex Assays Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Biological Multiplex Assays Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Biological Multiplex Assays Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Biological Multiplex Assays Revenue Breakdown by Type (2018-2029)
3 Biological Multiplex Assays Market Overview by Application
3.1 Introduction
3.1.1 Research And Development
3.1.2 Clinical Diagnosis
3.2 Global Biological Multiplex Assays Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Biological Multiplex Assays Historic Market Size by Application (2018-2023)
3.2.2 Global Biological Multiplex Assays Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Biological Multiplex Assays Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Biological Multiplex Assays Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Biological Multiplex Assays Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Biological Multiplex Assays Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Biological Multiplex Assays Revenue Breakdown by Application (2018-2029)
4 Biological Multiplex Assays Competition Analysis by Players
4.1 Global Biological Multiplex Assays Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biological Multiplex Assays as of 2022)
4.3 Date of Key Players Enter into Biological Multiplex Assays Market
4.4 Global Top Players Biological Multiplex Assays Headquarters and Area Served
4.5 Key Players Biological Multiplex Assays Product Solution and Service
4.6 Competitive Status
4.6.1 Biological Multiplex Assays Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Luminex
5.1.1 Luminex Profile
5.1.2 Luminex Main Business
5.1.3 Luminex Biological Multiplex Assays Products, Services and Solutions
5.1.4 Luminex Biological Multiplex Assays Revenue (US$ Million) & (2018-2023)
5.1.5 Luminex Recent Developments
5.2 Thermo Fisher Scientific
5.2.1 Thermo Fisher Scientific Profile
5.2.2 Thermo Fisher Scientific Main Business
5.2.3 Thermo Fisher Scientific Biological Multiplex Assays Products, Services and Solutions
5.2.4 Thermo Fisher Scientific Biological Multiplex Assays Revenue (US$ Million) & (2018-2023)
5.2.5 Thermo Fisher Scientific Recent Developments
5.3 Illumina
5.3.1 Illumina Profile
5.3.2 Illumina Main Business
5.3.3 Illumina Biological Multiplex Assays Products, Services and Solutions
5.3.4 Illumina Biological Multiplex Assays Revenue (US$ Million) & (2018-2023)
5.3.5 Bio-Rad Laboratories Recent Developments
5.4 Bio-Rad Laboratories
5.4.1 Bio-Rad Laboratories Profile
5.4.2 Bio-Rad Laboratories Main Business
5.4.3 Bio-Rad Laboratories Biological Multiplex Assays Products, Services and Solutions
5.4.4 Bio-Rad Laboratories Biological Multiplex Assays Revenue (US$ Million) & (2018-2023)
5.4.5 Bio-Rad Laboratories Recent Developments
5.5 Qiagen
5.5.1 Qiagen Profile
5.5.2 Qiagen Main Business
5.5.3 Qiagen Biological Multiplex Assays Products, Services and Solutions
5.5.4 Qiagen Biological Multiplex Assays Revenue (US$ Million) & (2018-2023)
5.5.5 Qiagen Recent Developments
5.6 Abcam
5.6.1 Abcam Profile
5.6.2 Abcam Main Business
5.6.3 Abcam Biological Multiplex Assays Products, Services and Solutions
5.6.4 Abcam Biological Multiplex Assays Revenue (US$ Million) & (2018-2023)
5.6.5 Abcam Recent Developments
5.7 Becton Dickinson
5.7.1 Becton Dickinson Profile
5.7.2 Becton Dickinson Main Business
5.7.3 Becton Dickinson Biological Multiplex Assays Products, Services and Solutions
5.7.4 Becton Dickinson Biological Multiplex Assays Revenue (US$ Million) & (2018-2023)
5.7.5 Becton Dickinson Recent Developments
5.8 Merck
5.8.1 Merck Profile
5.8.2 Merck Main Business
5.8.3 Merck Biological Multiplex Assays Products, Services and Solutions
5.8.4 Merck Biological Multiplex Assays Revenue (US$ Million) & (2018-2023)
5.8.5 Merck Recent Developments
5.9 Agilent Technologies
5.9.1 Agilent Technologies Profile
5.9.2 Agilent Technologies Main Business
5.9.3 Agilent Technologies Biological Multiplex Assays Products, Services and Solutions
5.9.4 Agilent Technologies Biological Multiplex Assays Revenue (US$ Million) & (2018-2023)
5.9.5 Agilent Technologies Recent Developments
5.10 Meso Scale Diagnostics
5.10.1 Meso Scale Diagnostics Profile
5.10.2 Meso Scale Diagnostics Main Business
5.10.3 Meso Scale Diagnostics Biological Multiplex Assays Products, Services and Solutions
5.10.4 Meso Scale Diagnostics Biological Multiplex Assays Revenue (US$ Million) & (2018-2023)
5.10.5 Meso Scale Diagnostics Recent Developments
5.11 Randox Laboratories
5.11.1 Randox Laboratories Profile
5.11.2 Randox Laboratories Main Business
5.11.3 Randox Laboratories Biological Multiplex Assays Products, Services and Solutions
5.11.4 Randox Laboratories Biological Multiplex Assays Revenue (US$ Million) & (2018-2023)
5.11.5 Randox Laboratories Recent Developments
5.12 Quanterix
5.12.1 Quanterix Profile
5.12.2 Quanterix Main Business
5.12.3 Quanterix Biological Multiplex Assays Products, Services and Solutions
5.12.4 Quanterix Biological Multiplex Assays Revenue (US$ Million) & (2018-2023)
5.12.5 Quanterix Recent Developments
5.13 Bio-Techne
5.13.1 Bio-Techne Profile
5.13.2 Bio-Techne Main Business
5.13.3 Bio-Techne Biological Multiplex Assays Products, Services and Solutions
5.13.4 Bio-Techne Biological Multiplex Assays Revenue (US$ Million) & (2018-2023)
5.13.5 Bio-Techne Recent Developments
5.14 Olink
5.14.1 Olink Profile
5.14.2 Olink Main Business
5.14.3 Olink Biological Multiplex Assays Products, Services and Solutions
5.14.4 Olink Biological Multiplex Assays Revenue (US$ Million) & (2018-2023)
5.14.5 Olink Recent Developments
6 North America
6.1 North America Biological Multiplex Assays Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Biological Multiplex Assays Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Biological Multiplex Assays Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Biological Multiplex Assays Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Biological Multiplex Assays Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Biological Multiplex Assays Market Dynamics
11.1 Biological Multiplex Assays Industry Trends
11.2 Biological Multiplex Assays Market Drivers
11.3 Biological Multiplex Assays Market Challenges
11.4 Biological Multiplex Assays Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
